Testing effectiveness (Phase 2)Looking for participantsNCT07457528
What this trial is testing
Efficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC
Who this might be right for
Resectable Esophageal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 46